Logo image of ALVAP.PA

KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

EPA:ALVAP - Euronext Paris - Matif - FR0013419876 - Common Stock - Currency: EUR

4.91  +0.06 (+1.24%)

Fundamental Rating

7

Overall ALVAP gets a fundamental rating of 7 out of 10. We evaluated ALVAP against 49 industry peers in the Specialty Retail industry. Both the health and profitability get an excellent rating, making ALVAP a very profitable company, without any liquidiy or solvency issues. ALVAP is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make ALVAP a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year ALVAP was profitable.
ALVAP had a negative operating cash flow in the past year.
In the past 5 years ALVAP has always been profitable.
In the past 5 years ALVAP reported 4 times negative operating cash flow.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

ALVAP has a better Return On Assets (9.80%) than 93.88% of its industry peers.
The Return On Equity of ALVAP (16.03%) is better than 83.67% of its industry peers.
ALVAP has a Return On Invested Capital of 12.75%. This is amongst the best in the industry. ALVAP outperforms 89.80% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALVAP is significantly above the industry average of 8.30%.
Industry RankSector Rank
ROA 9.8%
ROE 16.03%
ROIC 12.75%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 4.35%, ALVAP is in the better half of the industry, outperforming 75.51% of the companies in the same industry.
ALVAP's Profit Margin has improved in the last couple of years.
ALVAP has a Operating Margin of 5.90%. This is in the better half of the industry: ALVAP outperforms 77.55% of its industry peers.
In the last couple of years the Operating Margin of ALVAP has grown nicely.
With a Gross Margin value of 23.53%, ALVAP is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
ALVAP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.9%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALVAP is creating value.
The number of shares outstanding for ALVAP remains at a similar level compared to 1 year ago.
ALVAP has more shares outstanding than it did 5 years ago.
ALVAP has a better debt/assets ratio than last year.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

ALVAP has an Altman-Z score of 4.70. This indicates that ALVAP is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.70, ALVAP belongs to the top of the industry, outperforming 89.80% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that ALVAP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.21, ALVAP belongs to the top of the industry, outperforming 89.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.7
ROIC/WACC1.86
WACC6.86%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

ALVAP has a Current Ratio of 3.30. This indicates that ALVAP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.30, ALVAP belongs to the top of the industry, outperforming 93.88% of the companies in the same industry.
A Quick Ratio of 1.76 indicates that ALVAP should not have too much problems paying its short term obligations.
ALVAP has a better Quick ratio (1.76) than 89.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

ALVAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.18%.
Measured over the past years, ALVAP shows a very strong growth in Earnings Per Share. The EPS has been growing by 97.48% on average per year.
The Revenue for ALVAP has decreased by -34.12% in the past year. This is quite bad
Measured over the past years, ALVAP shows a very strong growth in Revenue. The Revenue has been growing by 41.89% on average per year.
EPS 1Y (TTM)-21.18%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

ALVAP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.87% yearly.
ALVAP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.00% yearly.
EPS Next Y4.94%
EPS Next 2Y8.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.56%
Revenue Next 2Y3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.06, the valuation of ALVAP can be described as very cheap.
Based on the Price/Earnings ratio, ALVAP is valued cheaper than 95.92% of the companies in the same industry.
ALVAP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.45.
A Price/Forward Earnings ratio of 5.61 indicates a rather cheap valuation of ALVAP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 95.92% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, ALVAP is valued rather cheaply.
Industry RankSector Rank
PE 6.06
Fwd PE 5.61
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALVAP is valued cheaply inside the industry as 95.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.26
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

ALVAP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALVAP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.23
PEG (5Y)0.06
EPS Next 2Y8.87%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

ALVAP has a Yearly Dividend Yield of 3.68%.
ALVAP's Dividend Yield is rather good when compared to the industry average which is at 4.99. ALVAP pays more dividend than 85.71% of the companies in the same industry.
ALVAP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

ALVAP pays out 17.39% of its income as dividend. This is a sustainable payout ratio.
DP17.39%
EPS Next 2Y8.87%
EPS Next 3YN/A
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

KUMULUS VAPE

EPA:ALVAP (7/3/2025, 7:00:00 PM)

4.91

+0.06 (+1.24%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap15.07M
Analysts86
Price Target8.82 (79.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.39%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.06
Fwd PE 5.61
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 1.13
EV/EBITDA 3.26
EPS(TTM)0.81
EY16.5%
EPS(NY)0.88
Fwd EY17.83%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS19.77
BVpS5.37
TBVpS4.36
PEG (NY)1.23
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.03%
ROCE 17.84%
ROIC 12.75%
ROICexc 17.69%
ROICexgc 22.5%
OM 5.9%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexcg growth 3Y1.55%
ROICexcg growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.7
F-Score3
WACC6.86%
ROIC/WACC1.86
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.18%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y4.94%
EPS Next 2Y8.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year1.56%
Revenue Next 2Y3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.16%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year20.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A